Vincerx Pharma (VINC) Short Interest Ratio & Short Volume $0.30 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Vincerx Pharma Short Interest DataVincerx Pharma (VINC) has a short interest of 813,800 shares. This marks a -2.81% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 684,785 shares to cover all short positions.Current Short Interest813,800 sharesPrevious Short Interest837,300 sharesChange Vs. Previous Month-2.81%Dollar Volume Sold Short$284,016.20Short Interest Ratio1.6 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares33,556,000 sharesPercentage of Shares Shorted2.43%Today's Trading Volume358,154 sharesAverage Trading Volume684,785 sharesToday's Volume Vs. Average52% Short Selling Vincerx Pharma? Sign up to receive the latest short interest report for Vincerx Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVINC Short Interest Over TimeVINC Days to Cover Over TimeVINC Percentage of Float Shorted Over Time Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Vincerx Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024813,800 shares $284,016.20 -2.8%N/A1.6 $0.35 10/15/2024837,300 shares $318,090.27 +189.4%N/A1.8 $0.38 9/30/2024289,300 shares $207,138.80 -28.2%N/A0.7 $0.72 9/15/2024403,000 shares $283,832.90 +1.4%N/A2.2 $0.70 8/31/2024397,500 shares $325,950.00 -1.7%N/A2.1 $0.82 8/15/2024404,200 shares $242,115.80 +7.0%N/A2.1 $0.60 Get the Latest News and Ratings for VINC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024377,900 shares $240,873.46 -6.2%N/A2 $0.64 7/15/2024403,000 shares $281,414.90 -31.7%N/A1.5 $0.70 6/30/2024590,000 shares $477,900.00 +36.2%N/A0.9 $0.81 6/15/2024433,200 shares $294,316.08 -29.3%N/A0.6 $0.68 5/31/2024612,500 shares $386,487.50 +7.9%N/A0.8 $0.63 5/15/2024567,500 shares $424,433.25 -44.9%N/A0.6 $0.75 4/30/20241,030,000 shares $851,810.00 -14.2%6.0%0.9 $0.83 4/15/20241,200,000 shares $1.04 million +50.0%8.9%1.1 $0.87 3/31/2024799,900 shares $4.05 million -7.4%5.9%0.6 $5.06 3/15/2024863,700 shares $4.82 million +95.2%6.4%0.8 $5.58 2/29/2024442,400 shares $1.66 million +83.3%3.3%0.5 $3.75 2/15/2024241,400 shares $415,208.00 -29.9%1.8%0.3 $1.72 1/31/2024344,200 shares $450,902.00 -32.8%2.6%0.7 $1.31 1/15/2024512,500 shares $702,125.00 +375.9%3.8%1.1 $1.37 12/31/2023107,700 shares $127,086.00 -12.6%0.8%0.2 $1.18 12/15/2023123,200 shares $77,739.20 -20.1%0.9%1.8 $0.63 11/30/2023154,200 shares $100,230.00 +19.8%1.2%3 $0.65 11/15/2023128,700 shares $99,871.20 -1.3%1.0%2.4 $0.78 10/31/2023130,400 shares $120,567.84 -10.6%1.0%1.6 $0.92 10/15/2023145,800 shares $141,426.00 -13.7%1.1%1.2 $0.97 9/30/2023168,900 shares $170,589.00 -3.7%1.3%1.4 $1.01 9/15/2023175,400 shares $154,352.00 -11.8%1.3%1.3 $0.88 8/31/2023198,900 shares $131,274.00 +87.8%1.5%1.5 $0.66 8/15/2023105,900 shares $91,074.00 -18.5%0.8%0.8 $0.86 7/31/2023129,900 shares $140,292.00 +8.3%1.0%1.2 $1.08 7/15/2023120,000 shares $150,000.00 -76.7%0.9%1.3 $1.25 6/30/2023514,100 shares $668,330.00 -18.6%4.0%5.8 $1.30 6/15/2023631,300 shares $965,889.00 +5.4%4.9%8.1 $1.53 5/31/2023599,200 shares $1.11 million -3.1%4.6%8.5 $1.85 5/15/2023618,300 shares $989,280.00 +1.9%4.4%10.3 $1.60 4/30/2023607,000 shares $795,170.00 +3.7%4.3%10.5 $1.31 4/15/2023585,200 shares $575,134.56 +0.7%4.1%10 $0.98 3/31/2023581,100 shares $604,344.00 +0.6%4.1%10.1 $1.04 3/15/2023577,700 shares $549,392.70 -0.4%3.5%7.9 $0.95“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. 2/28/2023580,000 shares $672,800.00 +0.8%3.6%3 $1.16 2/15/2023575,500 shares $673,335.00 -1.2%3.6%2.8 $1.17 1/31/2023582,300 shares $879,273.00 -1.6%3.6%2.5 $1.51 1/15/2023591,900 shares $627,414.00 -12.8%3.6%2.6 $1.06 12/30/2022678,700 shares $692,274.00 -31.4%4.2%2.8 $1.02 12/15/2022989,200 shares $797,493.04 +59.4%6.1%4.1 $0.81 11/30/2022620,500 shares $434,350.00 -6.5%3.8%5.1 $0.70 11/15/2022663,900 shares $542,273.52 +0.6%4.1%6 $0.82 10/31/2022660,100 shares $706,307.00 +6.2%4.0%6.2 $1.07 10/15/2022621,700 shares $714,955.00 -60.4%3.8%6.1 $1.15 9/30/20221,570,000 shares $2.17 million +2.6%9.6%18 $1.38 9/15/20221,530,000 shares $2.20 million No Change9.3%10.6 $1.44 8/31/20221,530,000 shares $2.33 million -3.2%9.4%8.3 $1.52 8/15/20221,580,000 shares $2.58 million +1.9%9.7%8.3 $1.63 7/31/20221,550,000 shares $2.17 million +0.7%9.5%9 $1.40 7/15/20221,540,000 shares $2.25 million -4.4%9.5%8.9 $1.46 6/30/20221,610,000 shares $2.13 million -10.6%11.0%9.4 $1.32 6/15/20221,800,000 shares $2.65 million +1.1%12.2%11.1 $1.47 5/31/20221,780,000 shares $2.90 million +0.6%12.1%20.3 $1.63 5/15/20221,770,000 shares $3.81 million +0.6%N/A21.3 $2.15 4/30/20221,760,000 shares $4.54 million +2.9%N/A20.8 $2.58 4/15/20221,710,000 shares $4.94 million +7.6%N/A16.1 $2.89 3/31/20221,590,000 shares $6.36 million +13.6%N/A12.7 $4.00 3/15/20221,400,000 shares $5.71 million +6.9%N/A11.5 $4.08 2/28/20221,310,000 shares $6.64 million +1.6%N/A10.4 $5.07 2/15/20221,290,000 shares $8.48 million +13.2%8.8%10.3 $6.57 1/31/20221,140,000 shares $8.20 million +24.6%8.0%9.4 $7.19 1/15/2022915,000 shares $7.32 million +10.1%6.2%9.8 $8.00 12/31/2021831,100 shares $8.47 million +13.1%5.7%11.4 $10.19 12/15/2021734,800 shares $7.62 million +0.7%5.0%9.4 $10.37 11/30/2021729,700 shares $7.65 million -6.6%5.0%7.7 $10.49 11/15/2021781,300 shares $9.77 million +1.9%5.3%7.1 $12.50 10/29/2021766,600 shares $10.71 million -3.4%5.7%6.3 $13.97 10/15/2021793,500 shares $11.78 million -36.0%7.1%5.9 $14.85 9/30/20211,240,000 shares $20.05 million +12.7%11.1%8.7 $16.17 9/15/20211,100,000 shares $17.40 million -5.2%9.8%6.4 $15.82 8/31/20211,160,000 shares $18.19 million +63.9%10.3%7 $15.68 8/13/2021707,700 shares $9.17 million -2.6%6.3%4.6 $12.96 7/30/2021726,200 shares $9.62 million -3.0%6.5%4.8 $13.25 7/15/2021748,700 shares $10.80 million -1.7%6.7%5.3 $14.42 6/30/2021761,900 shares $9.90 million +65.5%6.8%5.6 $12.99 6/15/2021460,500 shares $5.73 million -6.2%4.1%4.7 $12.44 5/28/2021490,700 shares $6.81 million +2.9%3.0%5.1 $13.88 5/14/2021477,000 shares $7.79 million -12.1%3.0%4.8 $16.34 4/30/2021542,800 shares $8.96 million -6.5%3.3%5.3 $16.50 4/15/2021580,500 shares $11.06 million -6.7%4.5%6.1 $19.05 3/31/2021622,000 shares $12.02 million +13.0%4.8%6.3 $19.33 3/15/2021550,500 shares $12.37 million +17.5%4.2%5.6 $22.47 2/26/2021468,700 shares $8.86 million -16.4%3.6%6.5 $18.90 2/12/2021560,400 shares $9.52 million +66.3%4.3%10.2 $16.98“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. 1/29/2021337,000 shares $6.26 million +317.6%2.7%8.8 $18.57 1/15/202180,700 shares $1.63 million No Change0.7%2.4 $20.20 VINC Short Interest - Frequently Asked Questions What is Vincerx Pharma's current short interest? Short interest is the volume of Vincerx Pharma shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 813,800 shares of VINC short. Learn More on Vincerx Pharma's current short interest. What is a good short interest ratio for Vincerx Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VINC shares currently have a short interest ratio of 2.0. Learn More on Vincerx Pharma's short interest ratio. Is Vincerx Pharma's short interest increasing or decreasing? Vincerx Pharma saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 813,800 shares, a decline of 2.8% from the previous total of 837,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Vincerx Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vincerx Pharma: CERo Therapeutics Holdings, Inc. (3.91%), DURECT Co. (3.35%), Lantern Pharma Inc. (2.06%), Daré Bioscience, Inc. (0.35%), CalciMedica, Inc. (1.36%), OKYO Pharma Limited (1.11%), Lexaria Bioscience Corp. (1.72%), Clene Inc. (2.91%), Lumos Pharma, Inc. (1.54%), BioLineRx Ltd. (1.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Vincerx Pharma stock? Short selling VINC is an investing strategy that aims to generate trading profit from Vincerx Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vincerx Pharma? A short squeeze for Vincerx Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VINC, which in turn drives the price of the stock up even further. How often is Vincerx Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VINC, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies CERo Therapeutics Short Squeeze DURECT Short Squeeze Lantern Pharma Short Squeeze Daré Bioscience Short Squeeze CalciMedica Short Squeeze OKYO Pharma Short Squeeze Lexaria Bioscience Short Squeeze Clene Short Squeeze Lumos Pharma Short Squeeze BioLineRx Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VINC) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this BEFORE November 19th.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredWhat the “Crypto President” means for your moneyDonald Trump has already promised to America's "crypto President"... to bring all bitcoin mining to the USA......Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
